Pharmacovigilance (PV) is the science and set of activities aimed at detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems throughout a medicine's life cycle. It is crucial for monitoring the benefit-risk balance of medicines to ensure patient safety, covering everything from pre-approval clinical trials to post-marketing surveillance. Effective PV allows regulatory authorities to take action to improve the safe use of medicines. 

Key aspects of pharmacovigilance include:

• Safety Monitoring: Identifying previously unrecognized adverse effects or changes in patterns of known side effects.
• Signal Detection: Analyzing individual case safety reports to identify potential new risks
• Risk Management: Implementing measures to minimize risks, such as updating product information (Summary of Product Characteristics) or using tools like the "Black Triangle" scheme for closely monitored, new medicines.
• Reporting Requirements: Collecting data from various sources (clinicians, patients, literature) and reporting to regulatory authorities like the MHRA (via the Yellow Card scheme) or EMA.

Scope: Beyond adverse drug reactions (ADRs), modern PV covers lack of efficacy, medication errors, misuse, abuse, and pregnancy exposure. 

Safety oversight and the ability to interact professionally in a complex world, is what our three levels of online PV training support.

1)      All must know how to identify and report an ADR.
2)      Those in PV or interacting with PV benefit from a broad understanding of PV obligations and tasks.
3)      Those handling PV on a national scale needs additional support to fulfil their role.

Click here for brochure

Fantastic rates available for groups of 5 or more participants - contact us for details

Our ‘on demand’ training is supported by certificates and can be downloaded conveniently on any smart device/phone.

Our online brochure can be found at https://brookwood-global.com/Books/Online-Training-Brochure/